G Gutierrez, C Clark, SD Brown, K Price, L Ortiz and C Nelson
Division of Pulmonary and Critical Care Medicine, University of Texas Health Science Center, Houston 77030.

Decreases in gastric mucosal pH (pHi) are associated with splanchnic hypoxia in animals and with increased mortality in patients. In the present study we measured changes in gastric pHi with a tonometer in septic patients after a short-term infusion of dobutamine. These changes were compared with concurrent alterations in systemic O2 consumption (VO2) and arterial lactate. Twenty-one patients admitted sequentially to a medical intensive care unit with sepsis and gastric pHi < 7.32 were prospectively separated into a normal lactate group (< or = 2.2 mM; n = 10) and an elevated lactate group (> 2.2 mM; n = 11). Dobutamine HCl was infused intravenously at 5 micrograms/kg/min for approximately 3 h and then increased to 10 micrograms/kg/min. Measurements were obtained after each increase in the dose of dobutamine. Dobutamine infused at 10 micrograms/kg/min produced increases in O2 transport in both groups (p < 0.05) whereas systemic O2 consumption remained unchanged. These changes were accompanied by decreases in the arterial lactate concentration of the elevated lactate group (p < 0.01). Arterial lactate remained constant in the normal lactate group. Gastric pHi increased in both groups when dobutamine was infused at 5 micrograms/kg/min (p < 0.01), and then again at 10 micrograms/kg/min (p < 0.05). These results imply that regional tissue hypoxia, as characterized by a low gastric pHi, may be present in septic patients with normal arterial lactate concentration. Moreover, a rise in gastric pHi in response to increases in systemic O2 transport may be a better indicator of regional hypoxia in septic patients than related increases in systemic VO2.

This article has been cited by other articles:

				A. Raddatz, D. Kubulus, J. Winning, I. Bauer, S. Pradarutti, B. Wolf, S. Kreuer, and H. Rensing Dobutamine Improves Liver Function after Hemorrhagic Shock through Induction of Heme Oxygenase-1 Am. J. Respir. Crit. Care Med., July 15, 2006; 174(2): 198 - 207. [Abstract] [Full Text] [PDF]

				M. Agusti, J. I. Elizalde, R. Adalia, G. Martinez-Palli, J. C. Garcia-Valdecasas, J. M. Pique, and P. Taura The Effects of Vasoactive Drugs on Hepatic Blood Flow Changes Induced by CO2 Laparoscopy: An Animal Study Anesth. Analg., November 1, 2001; 93(5): 1121 - 1126. [Abstract] [Full Text] [PDF]

				T. KOCH, S. GEIGER, and M. J. R. RAGALLER Monitoring of Organ Dysfunction in Sepsis/Systemic Inflammatory Response Syndrome: Novel Strategies J. Am. Soc. Nephrol., February 1, 2001; 12(90001): 53S - 59. [Abstract] [Full Text]

				R. G. Fiddian-Green and M. P. Fink Monitoring of Tissue pH : The Critical Measurement Chest, December 1, 1999; 116(6): 1839 - 1841. [Full Text] [PDF]

				L.-M. JOLY, M. MONCHI, A. CARIOU, J.-D. CHICHE, F. BELLENFANT, F. BRUNET, and J.-F. DHAINAUT Effects of Dobutamine on Gastric Mucosal Perfusion and Hepatic Metabolism in Patients with Septic Shock Am. J. Respir. Crit. Care Med., December 1, 1999; 160(6): 1983 - 1986. [Abstract] [Full Text]

				J. CRETEUR, D. DE BACKER, and J.-L. VINCENT A Dobutamine Test Can Disclose Hepatosplanchnic Hypoperfusion in Septic Patients Am. J. Respir. Crit. Care Med., September 1, 1999; 160(3): 839 - 845. [Abstract] [Full Text]